Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (201-210 of 393) with videos related to

Pageof 40
Sort By:
JAMA Network Open|August 7, 2020
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial ResultsMuhammad Shahzeb Khan, Gregg C Fonarow, Tim Friede, et al.
Brain, Behavior, and Immunity|June 21, 2024
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progressionSönke von Drathen, Stefan Michael Gold, Julia Peper, et al.
Arthritis Care & Research|December 17, 2013
Design and development of a decision support package for low back painShilpa Patel, Anne Ngunjiri, Harbinder Sandhu, et al.
NPJ Primary Care Respiratory Medicine|December 22, 2021
Acute respiratory infections in an adult refugee population: an observational studyAlexandra Jablonka, Christian Dopfer, Christine Happle, et al.
European Journal of Heart Failure|January 29, 2025
Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failureStefan D Anker, Tim Friede, Javed Butler, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2024
Which trial do we need? Shorter antifungal treatment for candidemia - challenging the 14-day dogmaNico Bekaan, Oliver A Cornely, Tim Friede, et al.
BMC Public Health|June 23, 2011
Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessmentAileen Clarke, Tim Friede, Rebecca Putz, et al.
Fortschritte Der Neurologie-Psychiatrie|October 16, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Pageof 40

Showing results (201-210 of 393) with videos related to

Sort By:
Pageof 40
JAMA Network Open|August 7, 2020
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial ResultsMuhammad Shahzeb Khan, Gregg C Fonarow, Tim Friede, et al.
Brain, Behavior, and Immunity|June 21, 2024
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progressionSönke von Drathen, Stefan Michael Gold, Julia Peper, et al.
Arthritis Care & Research|December 17, 2013
Design and development of a decision support package for low back painShilpa Patel, Anne Ngunjiri, Harbinder Sandhu, et al.
NPJ Primary Care Respiratory Medicine|December 22, 2021
Acute respiratory infections in an adult refugee population: an observational studyAlexandra Jablonka, Christian Dopfer, Christine Happle, et al.
European Journal of Heart Failure|January 29, 2025
Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failureStefan D Anker, Tim Friede, Javed Butler, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2024
Which trial do we need? Shorter antifungal treatment for candidemia - challenging the 14-day dogmaNico Bekaan, Oliver A Cornely, Tim Friede, et al.
BMC Public Health|June 23, 2011
Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessmentAileen Clarke, Tim Friede, Rebecca Putz, et al.
Fortschritte Der Neurologie-Psychiatrie|October 16, 2020
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018]Peter Flachenecker, Kerstin Eichstädt, Klaus Berger, et al.
Pageof 40